Scripps Research Institute, Takeda expand research collaboration

This is an extention to the initial collaboration between scientists on the Florida campus of TSRI and Envoy Therapeutics in 2010 that led to several breakthroughs in identifying potential new compounds for neurological and psychiatric diseases.

TSRI business development vice president Scott Forrest said, "The high-throughput screening capability at Scripps Florida campus is in increasing demand — both from other research institutes and from industry."

Envoy drug discovery senior vice president Stephen Hitchcock said, "The interaction between our scientists and theirs was a huge factor in expanding our research."

Scripps Florida’s high-throughput screening facility has expertise in transforming slow, labor-intensive biological and biochemical bench-top experiments into high-throughput screening experiments.